New data indicate that a patient’s risk of developing cervical pre-cancer or cancer can be estimated using current screening test results and previous screening test and biopsy results, while considering personal factors such as age and immunosuppression.
For a given current results and history combination, the immediate CIN 3+ risk is examined.
If this risk is 4% or greater, immediate management via colposcopy or treatment is indicated.
If the immediate risk is less than 4%, the 5 – year CIN 3+ risk is examined to determine whether patients should return in 1, 3 or 5 years.
Routine screening applies only to asymptomatic individuals who do not require surveillance for prior abnormal screening results.
